European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years

Autor: D S Bordin, Yu V Embutnieks, L G Vologzhanina, T A Ilchishina, I N Voynovan, A S Sarsenbaeva, O V Zaitsev, S A Alekseenko, R A Abdulkhakov, N N Dehnich, M F Osipenko, M A Livzan, V V Tsukanov, S G Burkov, N V Bakulina, E Yu Plotnikova, L V Tarasova, I V Maev, Yu A Kucheryavyi, N V Baryshnikova, M A Butov, S V Kolbasnikov, A L Pakhomova, T V Zhestkova, A Yu Baranovsky, S R Abdulhakov, E A Ageeva, E A Lyalyukova, A V Vasyutin, N N Golubev, I V Savilova, L V Morkovkina, A G Kononova, Francis Megraud, Colm O'Morain, Mercedes Ramas, Olga P Nyssen, Adrian G McNicholl, Javier P Gisbert
Jazyk: ruština
Rok vydání: 2019
Předmět:
Zdroj: Терапевтический архив, Vol 91, Iss 2, Pp 16-24 (2019)
Druh dokumentu: article
ISSN: 0040-3660
2309-5342
00403660
DOI: 10.26442/00403660.2019.02.000156
Popis: The multicenter prospective observational study initiated by the European Helicobacter and Microbiota Study Group (EHMSG) is conducted in 27 countries in Europe. The data from the Russian part of the European registry for the management of Helicobacter pylori infection (European Registry on the management of Helicobacter pylori infection, protocol: “Hp-EuReg”) allows us to analyze the real clinical practice of diagnosis and treatment of H. pylori and compare it with international recommendations. Materials and methods. A comparative analysis of the data entered in the register by the Russian research centers “Hp-EuReg”, in the period from 2013 to 2018, was conducted. Results and discussion. Invasive diagnostic methods prevail for the primary diagnosis of H. pylori [histology - 20.3% (in 2013 year) - 43.9% (in 2018 year), rapid urease test - 31.7% and 47.8% respectively]. The most popular mode of eradication therapy is a 10-day triple therapy (62.8-76.2%), the effectiveness of which does not exceed 79% (per protocol). Invasive tests (histology) are the leading method for control the effectiveness of therapy, however, there is a tendency towards a wider use of non-invasive methods (H. pylori stool antigen - from 17% in 2013 to 29.3% in 2018 and urea breath test from 6.9 to 18.3%, respectively). Serological test to control the effectiveness of eradication is still used from 8.2% (2013) to 6.1% (2018). Eradication therapy was not performed in 28% of patients throughout the entire observation period. Conclusion. In Russia, despite approved domestic and international recommendations, deviations in clinical practice persist, both during eradication therapy and in monitoring the effectiveness of eradication therapy.
Databáze: Directory of Open Access Journals
Externí odkaz: